Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmor. Jap.smls Regulatory News (JPSS)

  • There is currently no data for JPSS

Portfolio Management Team Changes

19 Jan 2022 07:00

RNS Number : 8787Y
JPMorgan Japan Small Cap G&I PLC
19 January 2022
 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN JAPAN SMALL CAP GROWTH & INCOME PLC

(the 'Company') 

 

PORTFOLIO MANAGEMENT TEAM CHANGES

 

Legal Entity Identifier: 549300KP3CRHPQ4RF811

The Board of JPMorgan Japan Small Cap Growth & Income plc has been informed by its Manager, JPMorgan Funds Limited, that Eiji Saito, the Company's lead portfolio manager, will be leaving JPMorgan after 18 years' service. Eiji has made the decision to leave the industry after 26 years to return to university and pursue a degree in law. Eiji has been a valuable member of the team and led JPMorgan Asset Management's Japan Small/Mid Cap strategy over the last 18 years.

 

Eiji's specific portfolio management responsibilities will be transitioned to other members of the JPMorgan Asset Management's Japanese Equity team.

 

Miyako Urabe will replace Eiji as the lead manager of the Company and the JPMorgan Asset Management's Japan Small/Mid Cap strategy. Miyako has spent 14 years within the industry, including 9 years at JPMorgan, having joined the Japanese Equities team in 2013. She has been a named manager on the multi-cap Japan Growth Unconstrained strategy since 2015.

 

Xuming Tao will join Miyako as a portfolio manager of the Company. Xuming was recruited to the team in 2019 as an investment analyst to focus on Japanese Small Cap research and has worked closely with the managers of JPMorgan Asset Management's Japan Small/Mid Cap strategy since then.

 

Nao Ozawa will continue as a portfolio manager of the Company, working alongside Miyako and Xuming. Nao has spent 16 years in the industry, 14 years with JPMorgan and 4 years managing the Company. Michiko Sakai will leave the team to focus on the JPM Japan Sustainable strategy responsibilities.

 

The three portfolio managers will continue to work closely with the highly experienced team in Tokyo that has been managing Japanese equities mandates since 1969. They are supported by JPMorgan Asset Management's extensive resources around the world.

 

The Company will continue to pay quarterly dividends without compromising the objective of achieving capital growth, funded from dividends from investment holdings and capital reserves, equivalent to 1% of its net asset value. There is no change to the investment objectives or investment policies of the Company. These management changes will come into effect immediately (on 19th January 2022).

 

The Board would like to thank Eiji for his contribution to the management of the Company. It looks forward to working with the portfolio management team and welcomes the new co-managers, Miyako and Xuming.

 

19th January 2022

 

For further information, please contact:

 

Divya Amin

For and on behalf of

JPMorgan Funds Limited

020 7742 4000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVALAITLIF
Date   Source Headline
20th Nov 202311:23 amRNSNet Asset Value(s)
17th Nov 20235:15 pmRNSTransaction in Own Shares
17th Nov 202310:51 amRNSNet Asset Value(s)
16th Nov 202310:40 amRNSNet Asset Value(s)
15th Nov 202311:33 amRNSNet Asset Value(s)
14th Nov 202310:34 amRNSNet Asset Value(s)
13th Nov 202312:16 pmRNSGearing Announcement
13th Nov 202311:24 amRNSNet Asset Value(s)
13th Nov 202311:05 amRNSTen largest Investments
10th Nov 202310:15 amRNSNet Asset Value(s)
9th Nov 202311:01 amRNSNet Asset Value(s)
8th Nov 202310:30 amRNSNet Asset Value(s)
7th Nov 202310:17 amRNSNet Asset Value(s)
6th Nov 20231:02 pmRNSGearing Announcement
6th Nov 202312:00 pmRNSNet Asset Value(s)
3rd Nov 202310:43 amRNSNet Asset Value(s)
2nd Nov 202311:11 amRNSNet Asset Value(s)
1st Nov 202312:49 pmRNSNet Asset Value(s)
1st Nov 202310:41 amRNSTotal Voting Rights
31st Oct 202311:49 amRNSNet Asset Value(s)
30th Oct 20231:56 pmRNSGearing announcement
30th Oct 202312:24 pmRNSNet Asset Value(s)
27th Oct 20235:20 pmRNSTransaction in Own Shares
27th Oct 202311:41 amRNSNet Asset Value(s)
26th Oct 202310:49 amRNSNet Asset Value(s)
25th Oct 202311:11 amRNSNet Asset Value(s)
24th Oct 202311:01 amRNSNet Asset Value(s)
23rd Oct 202311:46 amRNSGearing announcement
23rd Oct 202311:18 amRNSNet Asset Value(s)
20th Oct 20235:10 pmRNSTransaction in Own Shares
20th Oct 20231:52 pmRNSNet Asset Value(s)
19th Oct 202310:53 amRNSNet Asset Value(s)
18th Oct 20235:12 pmRNSTransaction in Own Shares
18th Oct 202311:03 amRNSNet Asset Value(s)
17th Oct 202311:16 amRNSNet Asset Value(s)
16th Oct 202312:46 pmRNSGearing announcement
16th Oct 202310:50 amRNSNet Asset Value(s)
13th Oct 202311:19 amRNSNet Asset Value(s)
12th Oct 20234:06 pmRNSTen Largest Investments
12th Oct 202311:09 amRNSNet Asset Value(s)
11th Oct 202311:07 amRNSNet Asset Value(s)
10th Oct 20235:04 pmRNSTransaction in Own Shares
10th Oct 202311:42 amRNSNet Asset Value(s)
9th Oct 20235:33 pmRNSTransaction in Own Shares
9th Oct 202312:54 pmRNSGearing Announcement
9th Oct 202311:24 amRNSNet Asset Value(s)
6th Oct 20235:23 pmRNSTransaction in Own Shares
6th Oct 202311:43 amRNSNet Asset Value(s)
5th Oct 202310:56 amRNSNet Asset Value(s)
4th Oct 202311:44 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.